Multiple studies have shown that the PI3K/AKT pathway is highly activated in B-ALL cells 26, 27, and inhibition of PI3K/AKT pathway leads to apoptotic activation in B-ALL cells 27. Here, AKT1 is linked to acute lymphoblastic leukemia.